@article{b129245d0ca542ffa0fe582b09ea19bf,
title = "PharmGKB summary: Heparin-induced thrombocytopenia pathway, adverse drug reaction",
keywords = "PharmGKB, adverse drug reaction, heparin, heparin-induced thrombocytopenia, pharmacogenetics, pharmacogenomics, thrombocytopenia, thrombosis",
author = "Elise Miller and Charles Norwood and Giles, {Jason B.} and Rachel Huddart and Karnes, {Jason H.} and Michelle Whirl-Carrillo and Klein, {Teri E.}",
note = "Funding Information: J.H.K. is supported by grants from the NIH{\textquoteright}s National Heart Lung and Blood Institute (NHLBI) under award numbers K01HL143137 and R01HL158686, the American College of Clinical Pharmacy and the Flinn Foundation. PharmGKB is supported by the NIH/NHGRI/NICHD grant U24 HG010615.",
year = "2022",
month = apr,
day = "1",
doi = "10.1097/FPC.0000000000000465",
language = "English (US)",
volume = "32",
pages = "117--124",
journal = "Pharmacogenetics and Genomics",
issn = "1744-6872",
publisher = "Lippincott Williams and Wilkins",
number = "3",
}